Open AccessUnilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: a multicenter international study
Author(s) -
Judith Staub,
Ali A. Siddiqui,
Megan Murphy,
Robert Lam,
Meet Parikh,
Douglas K. Pleskow,
Georgios I. Papachristou,
Reem Z. Sharaiha,
Usama Iqbal,
David E. Loren,
Thomas E. Kowalski,
Arish Noor,
Tayebah Mumtaz,
Ichiro Yasuda,
Samuel Thomas,
Abdul Hsaeeb,
Jennifer S. Herrick,
Tom Greene,
Douglas G. Adler
Publication year - 2020
Publication title -
annals of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 33
eISSN - 1792-7463
pISSN - 1108-7471
DOI - 10.20524/aog.2020.0451
Subject(s) - medicine , adverse effect , stent , surgery , hazard ratio , confidence interval , occlusion , retrospective cohort study
Endoscopic placement of hilar stents is an accepted palliative therapy for patients with advanced, unresectable cholangiocarcinoma. However, whether unilateral versus bilateral stent placement provides optimal relief continues to be a subject of debate. The aim of this study was to compare the technical and clinical outcomes in patients with inoperable cholangiocarcinoma who received unilateral or bilateral self-expanding metal stents (SEMS).